Adverse Drug Reaction Labelling for Atomoxetine, Methylphenidate and Modafinil: Comparison of Product Information for Oral Formulations in Australia, Denmark and the United States

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|8|3|162-168

ISSN： 1574-8863

Source： Current Drug Safety, Vol.8, Iss.3, 2013-07, pp. : 162-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ambulatory Care Visits for Treating Adverse Drug Effects in the United States, 1995–2001

By Zhan Chunliu   Arispe Irma   Kelley Edward   Ding Tina   Burt Catharine W.   Shinogle Judith   Stryer Daniel  

Joint Commission Journal on Quality and Patient Safety, Vol. 31, Iss. 7, 2005-07 ,pp. : 372-378

Joint Commission Resources

Access to resources Recommend Favorite

Adverse drug reaction reports of patients and healthcare professionals—differences in reported information

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 2, 2015-02 ,pp. : 152-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emergency Department Visits for Adverse Drug Reactions Involving Alcohol: United States, 2005 to 2011

By  

ALCOHOLISM (ELECTRONIC), Vol. 40, Iss. 9, 2016-09 ,pp. : 1913-1925

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of patterns of spontaneous adverse drug reaction reporting with St. John's Wort and fluoxetine during the period 2000–2013

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 7, 2015-07 ,pp. : 747-751

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of modafinil as a perpetrator of metabolic drug–drug interactions using a model informed cocktail reaction phenotyping trial protocol

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 501-509

John Wiley & Sons Inc

Access to resources Recommend Favorite